Erratum to: “Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain” [PAIN® 2013;154(10):1910–19]
| Autor: | Sanga, Panna, Katz, Nathaniel, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Haeussler, Juergen, Thipphawong, John |
|---|---|
| Zdroj: | In Pain January 2014 155(1):204-204 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|